Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Global Animal Model Market Outlook for 2024 to 2034

The global animal model market is estimated to garner a revenue of around US$ 1,943.3 million in 2024. Animals possess a shorter life cycle, a high genotype resemblance, and are easy to test in laboratories.

As per the animal model demand analysis report, the overall market is predicted to grow at a moderate CAGR of 6% over the next ten years. The report also forecasts the global animal model industry to reach a value of nearly US$ 3,476.8 million by the end of this forecast period.

Animal Model Market Trends and Analysis

  • Traditionally, animal models, like humanized mice, are used prominently in biomedical research that helps develop new treatment methods for various diseases. But, now, demand for different species of animals has increased in the healthcare sector as it offers a better understanding of other diseases, along with the efficacy of drugs with regard to many diseases.
  • The development of genetically modified animals for preclinical models that are more predictive in being effective is an arduous and time-consuming process. However, recent progress being made in animal studies and researchers applying new experimental approaches to elucidate the biology of specific diseases has curbed this challenge.
Report Attribute Details
Animal Model Market Revenue (2024) US$ 1,943.3 million
Market Anticipated Forecast Value (2034) US$ 3,476.8 million
Market Projected Growth Rate (2024 to 2034) 6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Global Animal Model Market Analysis During Historical Period from 2019 to 2023 Compared to Forecast Outlook for 2024 to 2034

In 2019, the net revenue generated by animal model suppliers and service providers was assessed to be around US$ 1,425 million. The global animal model market witnessed a growth rate of 6.4% from 2019 to 2023.

During this period, the animal model market had been facing tremendous pressure from animal welfare organizations and activists in various countries. However, the situation has changed drastically since the outbreak of COVID-19. This change in situation was due to animal model testing being central in research towards developing an effective vaccine against novel coronavirus or other pathogens.

Historical Market CAGR (2019 to 2023) 6.4%
Forecasted Market CAGR (2024 to 2034) 6%

The industry also received a significant fillip during this period due to a rapid rise in demand for non-human primates for research into COVID-19 vaccines. This research is expected to continue in the near future, driving the demand for different species for preclinical models.

Opportunities and Challenges for the Global Animal Model Market Growth

Alternatives such as cell cultures, tissue cultures, and computer models are also available. However, animal models are preferred owing to the complexity of the living systems. Significant incidence rates of diseases, along with adverse effects of drugs, have driven the adoption of animal models to ensure the safety of humans. So, the persisting demand for laboratory animals in pharmacological studies is expected to strengthen the market with the expansion of the pharmaceutical sector.

Pharmacological studies, which include target identification & validation, toxicology drug screening & lead optimization & safety screening, have also surged the demand for advanced animal models for preclinical research. For instance, according to the Pharmaceutical Research and Manufacturers of America, biopharmaceutical businesses spent roughly US$ 79.6 billion on research and development in the United States in 2018.

Government intervention in academic and research institutions is increasing for the development of standard protocols related to animal models. Researchers utilize animal models for basic research, such as developing new therapeutic strategies to treat human diseases and preclinical analyses of developed drug safety & efficacy. Moreover, continued advances in animal models, the availability of modern healthcare systems, and a considerable increase in demand for modern healthcare facilities are also expected to propel the market to some degree.

One of the major restraints in the adoption of some animal models is the risk of researchers using animal models being susceptible to false analogy, where implications built around assumptions of similarities between animals and humans can potentially lead to an incorrect conclusion.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View of the Adjacent Animal Model Market

The comparative analysis and market growth rate of adjacent markets reveal a clear picture of the future growth prospects for the market under discussion. The animal healthcare industry is subject to product development activities under the Animal Rule and growing demand for chronic disease therapeutics. On the other hand, the growth of the animal artificial insemination market is anticipated to strengthen the supply chains for animal model suppliers in the coming days.

Animal Model Market:

Attributes Animal Model Market
CAGR (2024 to 2034) 6%
Growth Factor Significant investments are being made in animal model research in the post-pandemic period.
Market Opportunities Increasing government intervention in research institutes to develop standard protocols associated with animal models.
Market Challenges The cost of animal research is high and results in delays in drug approvals that impact the demand for animal models.

Animal Healthcare Market:

Attributes Animal Healthcare Market
CAGR (2024 to 2034) 4.3%
Growth Factor The rising prevalence of foodborne and zoonotic diseases in livestock has increased the importance of animal healthcare products.
Market Opportunities Introduction of wearables, smart tags, sound-detecting devices, and predictive software for animal health monitoring.
Market Challenges Absence of vaccinations against many animal diseases and stringent regulatory clearance procedures required to commercialize them.

Animal Artificial Insemination Market:

Attributes Animal Artificial Insemination Market
CAGR (2024 to 2034) 6%
Growth Factor The rise in meat consumption in the developed countries and the demand for improving food security in low-income group countries.
Market Opportunities In collaboration with public organizations, government organizations are encouraging mass animal artificial insemination programs.
Market Challenges Limited awareness among small farmers about the advantages of artificial insemination techniques.

Country-wise Insights

The table below puts together the CAGRs for a few countries expected to witness a notable increment in their share of the animal model industry. In North American and European countries witness robust growth rates with relevant policies being reformed by the government to spur funding plans related to animal model research. Several animal model solution providers in Asia are also expected to make huge investments in biogenic research which is reflected in the promising growth rates of China and Japan.

Regional Market Comparison CAGR (2024 to 2034)
United States 6.7%
Germany 8.2%
United Kingdom 6.6%
Japan 4.7%
China 6.1%

USA Animal Model Market Size to Expand at a Moderate Rate

The demand for experimental animals in the United States for in vivo models is predicted to increase 6.7% through the projected years. The United States is likely to be a dominating country in the animal model market because of

  • Growth in research and experiment activities by biotech and pharmaceutical firms in the country.
  • Rise in CROs' use of animal models in response to the growing number of clinical trials.
  • An increased focus on personalized medications and large investments in these studies.

China to Gradually Increase its Supply of Translational Research Models

The market in China holds a significant share of the global market and is likely to maintain its dominance in Asia for laboratory animals for pharmacological studies. Some prominent factors that are expected to drive the China market at 6.1% CAGR through the forecast period include:

  • Increase in the number of programs and rising government spending on overall R&D of pharmaceuticals utilizing animal models.
  • Greater recognition of mouse clinical trials (MCTs) with genetic variations for estimating outcomes more accurately.
  • Chinese animal model suppliers focus on increasing their geographical presence to gain a large market share.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Rats are Still the Champions as Animal Research Models

Based on species, revenue from rat-based animal models is estimated to account for a 37.3% market share in 2024.

Attributes Details
Top Species Type or Segment Rats
Market Share in 2024 37.3%

Revenue from the use of rats in animal models is also slated to expand through the forecasted years due to the following reasons:

  • Growing adoption of rodent models to study a variety of complicated illnesses.
  • Rising demand for rat models in biomedical research to better understand current health challenges.
  • Developments in gene-editing techniques are expanding the mice model market size.

Drug Discovery to remain the Primary Application for Animal Testing Models

The development of animal models for drug discovery is expected to account for nearly 54.4% of the market share in 2024.

Attributes Details
Top Application Type Drug Discovery and Development
Market Share in 2024 54.4%

A few key factors that are expected to retain the dominance of the drug discovery and development segment through the forecast years include:

  • Higher requirement for biomedical research animals for achieving progress in healthcare and medical science is well-proven
  • Demand for animal model systems has gained support from international organizations.
  • Recent advancements in lab technologies have made disease-specific animal models safe and constructive.

Competitive Landscape

Key animal model system providers are focusing on strategic acquisitions, mergers, collaborations, and partnerships to grow their client base and boost their industrial position. Recent investments by leading companies have created prospects for the market to expand globally.

The market is now highly influenced by technological interventions in software modeling for time and cost efficiency, along with the growing ethical concerns in reducing the number of live animals used for research. Recent key developments in the market include the development of a novel monkey research model using CRISPR technology.

Recent Developments in the Global Animal Model Market

In January 2020, Horizon Discovery Group plc. confirmed a partnership and license deal with Mammoth Biosciences to gain access to Mammoth's unique CRISPR technology. The partnership is expected to make it easier for Horizon to provide a new generation of genetically altered CHO cells to manufacture biotherapeutics such as therapeutic antibodies.

In March 2022, Charles River Laboratories and Hera Biolabs inked a contract for the breeding, marketing, and sales of SRG rats to the world's preclinical research community. Through this deliberate partnership, Hera BioLabs is aiming to expand the geographic reach of its highly immunodeficient rat model.

Key Players Profiled in the Animal Model Market Report

  • Charles River Laboratories International, Inc.
  • Horizon Discovery Group plc.
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Genoway SA
  • Eurofins Scientific SE
  • Crown Bioscience, Inc.
  • Envigo CRS SA
  • Transposagen Biopharmaceuticals, Inc.

Animal Model Market Report Scope

Attribute Details
Estimated Market Size (2024) US$ 1,943.3 million
Projected Market Size (2034) US$ 3,476.8 million
Anticipated Growth Rate (2024 to 2034) 6%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis US$ million or billion for Value and Units for Volume
Key Regions Covered North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa
Key Segments Covered By Species Type, By Application, By End User, and By Region
Key Companies Profiled
  • Charles River Laboratories International, Inc.
  • Horizon Discovery Group plc.
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Genoway SA
  • Eurofins Scientific SE
  • Crown Bioscience, Inc.
  • Envigo CRS SA
  • Transposagen Biopharmaceuticals, Inc.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Key Segments Covered by Animal Model Industry Survey Report

By Species Type:

  • Rats
  • Mice
  • Guinea Pigs
  • Rabbits
  • Monkeys
  • Dogs
  • Pigs
  • Cats
  • Other Species

By Application:

  • Basic and Applied Research
  • Drug Discovery and Development
  • Other Applications

By End User:

  • Academic & Research Institutions
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Other End Users

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

What Big is the Global Animal Model Market Currently?

The global animal model market is estimated to be valued at US$ 1,943.3 million in 2024.

What is the Growth Outlook of the Animal Model Market?

The global animal model market is to grow at 6% during the forecast period.

What is the projected Value of Animal Model Market by 2033?

The global animal model market is predicted to be valued at US$ 3,476.8 million by 2034.

Which Country is the Dominant Share Holder in the Global Animal Model Market?

The United States accounts for over one-fourth revenue share of the global market.

Which Regional Animal Model Market has the Highest Growth Potential?

Germany is predicted to witness an 8.2% CAGR in the adoption of animal models through 2034.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Species

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Species, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Species, 2024 to 2034

        5.3.1. Rats

        5.3.2. Mice

        5.3.3. Guinea Pigs

        5.3.4. Rabbits

        5.3.5. Monkeys

        5.3.6. Dogs

        5.3.7. Pigs

        5.3.8. Cats

        5.3.9. Other Species

    5.4. Y-o-Y Growth Trend Analysis By Species, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Species, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034

        6.3.1. Academic & Research Institutions

        6.3.2. Pharmaceutical Companies

        6.3.3. Biotechnology Companies

        6.3.4. Contract Research Organizations (CROs)

        6.3.5. Other End Users

    6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2024 to 2034

        7.3.1. Basic and Applied Research

        7.3.2. Drug Discovery/Development

    7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Species

        9.2.3. By End User

        9.2.4. By Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Species

        9.3.3. By End User

        9.3.4. By Application

    9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Species

        10.2.3. By End User

        10.2.4. By Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Species

        10.3.3. By End User

        10.3.4. By Application

    10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Species

        11.2.3. By End User

        11.2.4. By Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Species

        11.3.3. By End User

        11.3.4. By Application

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Species

        12.2.3. By End User

        12.2.4. By Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Species

        12.3.3. By End User

        12.3.4. By Application

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Species

        13.2.3. By End User

        13.2.4. By Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Species

        13.3.3. By End User

        13.3.4. By Application

    13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Species

        14.2.3. By End User

        14.2.4. By Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Species

        14.3.3. By End User

        14.3.4. By Application

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Species

        15.2.3. By End User

        15.2.4. By Application

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Species

        15.3.3. By End User

        15.3.4. By Application

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2023

            16.1.2.1. By Species

            16.1.2.2. By End User

            16.1.2.3. By Application

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2023

            16.2.2.1. By Species

            16.2.2.2. By End User

            16.2.2.3. By Application

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2023

            16.3.2.1. By Species

            16.3.2.2. By End User

            16.3.2.3. By Application

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2023

            16.4.2.1. By Species

            16.4.2.2. By End User

            16.4.2.3. By Application

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2023

            16.5.2.1. By Species

            16.5.2.2. By End User

            16.5.2.3. By Application

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2023

            16.6.2.1. By Species

            16.6.2.2. By End User

            16.6.2.3. By Application

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2023

            16.7.2.1. By Species

            16.7.2.2. By End User

            16.7.2.3. By Application

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2023

            16.8.2.1. By Species

            16.8.2.2. By End User

            16.8.2.3. By Application

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2023

            16.9.2.1. By Species

            16.9.2.2. By End User

            16.9.2.3. By Application

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2023

            16.10.2.1. By Species

            16.10.2.2. By End User

            16.10.2.3. By Application

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2023

            16.11.2.1. By Species

            16.11.2.2. By End User

            16.11.2.3. By Application

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2023

            16.12.2.1. By Species

            16.12.2.2. By End User

            16.12.2.3. By Application

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2023

            16.13.2.1. By Species

            16.13.2.2. By End User

            16.13.2.3. By Application

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2023

            16.14.2.1. By Species

            16.14.2.2. By End User

            16.14.2.3. By Application

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2023

            16.15.2.1. By Species

            16.15.2.2. By End User

            16.15.2.3. By Application

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2023

            16.16.2.1. By Species

            16.16.2.2. By End User

            16.16.2.3. By Application

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2023

            16.17.2.1. By Species

            16.17.2.2. By End User

            16.17.2.3. By Application

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2023

            16.18.2.1. By Species

            16.18.2.2. By End User

            16.18.2.3. By Application

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2023

            16.19.2.1. By Species

            16.19.2.2. By End User

            16.19.2.3. By Application

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2023

            16.20.2.1. By Species

            16.20.2.2. By End User

            16.20.2.3. By Application

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2023

            16.21.2.1. By Species

            16.21.2.2. By End User

            16.21.2.3. By Application

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2023

            16.22.2.1. By Species

            16.22.2.2. By End User

            16.22.2.3. By Application

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2023

            16.23.2.1. By Species

            16.23.2.2. By End User

            16.23.2.3. By Application

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Species

        17.3.3. By End User

        17.3.4. By Application

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Charles River Laboratories International, Inc.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Horizon Discovery Group plc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. The Jackson Laboratory

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Taconic Biosciences, Inc.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Genoway SA

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Eurofins Scientific SE

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Crown Bioscience, Inc.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Envigo CRS SA

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Transposagen Biopharmaceuticals, Inc.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Animal Artificial Insemination Market

Published : June 2023

Healthcare

Animal Healthcare Market

Published : January 2023

Explore Healthcare Insights

View Reports